Business
Exercise of Options
Exercise of Options.
About this update from 4basebio Plc
[{"type":"text","content":"\n\n \n \n\n\n\n\n25 June 2025\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t4basebio PLC(\"4basebio\" or the \"Company\")Exercise of OptionsCambridge, UK, 25 June 2025 – 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform, announces that, on 19 June 2025, it received notification from two employees of the Company to exercise EMI options over 13,000 ordinary shares (“New Ordinary Shares”) in the Company at an exercise price of £1.18 per share, raising total proceeds of £15,340.Admission to AIMApplication will be made for the New Ordinary Shares to be admitted to trading on AIM (\"Admission\"). It is expected that Admission will become effective at 8:00 a.m. on or around 30 June 2025. The New Ordinary Shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after Admission and will otherwise rank on Admission pari passu in all respects with the existing ordinary shares.Total Voting RightsFollowing Admission, the total number of ordinary shares in issue will be 15,509,393. The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares with voting rights will be 15,509,393. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as amended by regulation 11 of the market abuse (amendment) (EU Exit) regulations 2019/310.For further enquiries, please contact:\t\t\t\t\t\t\t\t\t4basebio PLC\t\t\tDr. Heikki Lanckriet, CEO\t\t\t\t\t\t+44 (0)1223 967 943\t\t\t\t\t\t\t\t\t\tNominated Adviser \t\t\tCairn Financial Advisers LLP\t\t\tJo Tuner / Sandy Jamieson / Ed Downes\t\t\t\t\t\t+44 (0)20 7213 0880\t\t\t\t\t\t\t\t\t\tJoint Broker\t\t\tRBC Capital Markets\t\t\tKathryn Deegan / Matthew Coakes\t\t\t\t\t\t+44 (0)20 7653 4000\t\t\t\t\t\t\t\t\t\tJoint Broker\t\t\tCavendish Capital Markets Limited\t\t\tGeoff Nash / Nigel Birks\t\t\t\t\t\t+44 (0)20 7220 0...